Recent studies have demonstrated that targeting deubiquitinases can effectively reduce the post-translational levels of NRF2 and YAP proteins, thereby decreasing the growth and chemoresistance of pancreatic cancer cells [124]. Here, NFE2L2 is linked to familial pancreatic carcinoma.